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 ■ Abstract 
AIMS: Elevated plantar pressure is considered a significant 
risk factor for ulceration in diabetes mellitus. The aim of this 
study was to determine whether duration of diabetes could 
affect plantar pressure in patients with no known significant 
comorbidity or foot pathology. METHODS: Participants 
with type 2 diabetes, but without known confounding factors 
that could alter peak pressure, were matched for age, 
weight, and gender and categorized into 3 groups of diabe-
tes duration: group 1 (1-5 yr), group 2 (6-10 yr), and group 3 
(11-15 yr). Plantar pressures were recorded utilizing a two-
step protocol at a self-selected speed. RESULTS: One-way 
analysis of variance (ANOVA) revealed significant differ-
ences in mean peak plantar pressures between the three 
groups under the 2nd - 4th metatarsophalangeal joint (MPJ) 
region of interest (ROI) (p = 0.012 and p = 0.022, respec-
tively) and left heel (p = 0.049). Also, a significant difference 
in mean pressure-time integral under the left 2nd - 4th MPJ 
ROI (p = 0.021) and right heel (p = 0.048) was observed. Re-
gression analysis confirmed that mean peak plantar pres-
sures in the first group (but not in the second group) were 
significantly lower than in the third group (p = 0.005). 
CONCLUSIONS: As the duration of diabetes increased, 
peak plantar pressure increased significantly under the 2nd - 
4th MPJ ROIs. These findings suggest that clinicians should 
make more use of pressure mapping technology as part of 
their clinical management plan in patients with diabetes >10 
yr, even if they have no complications or deformities, to pre-
serve functional limbs in this high-risk population. 
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1. Introduction 
 
 iabetes mellitus may cause several complica- 
 tions. Foot ulceration and lower limb ampu- 
 tations are among the most severe and 
common complications [1]. People living with dia-
betes carry a risk of foot ulceration ranging from 4-
10%, with a lifetime risk of up to 25% [2]. Nearly 
85% of all amputations in people with diabetes are 
preceded by ulceration. Since a large percentage of 
diabetes-related lower limb amputations are po-
tentially avoidable, it is important to implement 
effective and practicable diabetic foot care proto-
cols in primary care settings to prevent these com-
plications [3]. 
Limited joint mobility [4, 5], structural foot de-
formities [6], intrinsic muscle weakness [7], and 
muscle atrophy [8] occur in both type 1 and type 2 
diabetes. These complications may occur as a re-
sult of hyperglycemia and play a significant role in 
increasing plantar pressures [9]. 
Plantar pressure measurement is frequently 
used to assess gait conditions associated with dia-
betes as excessive pressure in specific areas may 
cause foot ulceration in patients with diabetes. 
Abnormal patterns of foot loading in these patients 
caused by abnormal gait that has developed over 
time may lead to various foot complications such 
as ulcers. Changes in foot pressures can be deter-
mined by assessing peak plantar pressures or 
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pressure-time integral [5]. Although Anjos et al. 
reported that patients living with diabetes for 
more than 10 years may have increased peak plan-
tar pressure [9], which is also supported by Tuna 
et al. [10], there is a clear paucity of information 
regarding this matter. 
Alterations in the distribution of plantar pres-
sure may be due to several factors, including 
changes in the anatomical structure of the foot and 
deformities [11]. When subjects with diabetes and 
a history of ulceration were compared with those 
without ulceration or healthy individuals, higher 
plantar pressures were noted on the lateral side of 
the forefoot area [12]. 
The majority of previous studies evaluated the 
roles of established peripheral neuropathy [13, 14] 
and peripheral vascular disease [15] as major 
causes of plantar pressure abnormalities. Few 
studies have examined plantar pressure distribu-
tion in patients with type 2 diabetes (T2D) without 
neuropathy [16]. It has been suggested that foot 
pressure abnormality may represent an early 
marker of diabetic peripheral neuropathy. 
A peak plantar pressure threshold higher than 
6 kg/cm2 (588.6 kPa) during walking has been hy-
pothesized as the pressure threshold that can 
cause soft tissue damage in high-risk patients with 
T2D [17]. Another study reported that the peak 
plantar pressure threshold in patients with T2D 
and hammer or claw toe deformation measured 
621 kPa under the second and third metatarsal 
head [18]. This increase in plantar pressure is at-
tributed to a distal displacement of the protective 
fat pad under the metatarsophalangeal joints, 
such that plantar pressure is transferred proxi-
mally under the metatarsal heads. This reduced 
plantar tissue thickness is associated with higher 
peak plantar pressures, indicating greater risk of 
forefoot ulceration [6]. Continuous pulling on the 
metatarsal heads and thickening of the plantar 
fascia and Achilles tendon together with neuropa-
thy may further increase pressure in the forefoot 
[19]. On the other hand, Fawzy et al. report that 
peak plantar pressure threshold before ulceration 
may be as low as 335 kPa [26]. 
Screening for diabetes involves the identifica-
tion of asymptomatic individuals who are at high 
risk of developing the disease or its complications 
through appropriate screening tests [20]. Hence, 
the investigation of peak plantar pressure altera-
tions in the non-symptomatic diabetic foot may be 
an important procedure for avoiding foot complica-
tions in high-risk individuals. This consideration 
has prompted this study, the aim of which is to in-
vestigate the relationship between duration of dia- 
 
betes and plantar pressure in the absence of sig-
nificant deformity or neuropathy. 
2. Methods 
2.1 Participants 
The participants were recruited from a diabetes 
primary care outpatient clinic. Ethical approval 
was obtained from the University Research Ethics 
Committee, and all participants gave informed 
consent prior to inclusion in the study to meet the 
World Medical Association (2013) standards. 
Thirty-six participants (61% male, 39% female) 
without foot deformities (i.e. with a neutral foot 
posture index (FPI) score of 0 to +5) were re-
cruited. The participants were divided into 3 
groups according to disease duration matched for 
age, gender, and body weight, as follows: 
 
- Group 1: 12 participants who had lived with 
T2D for the past 5 years. 
- Group 2: 12 participants who had lived with 
T2D for 6 to 10 years. 
- Group 3: 12 participants who had lived with 
T2D for 11 to 15 years. 
 
The participant age and weight parameters are 
shown in Table 1. 
3.2 Assessment of neuropathy 
All participants were initially assessed for the 
presence of sensory peripheral neuropathy by 5.07 
Semmes-Weinstein monofilament and vibration 
perception threshold using a tuning fork. The 
monofilament was applied to the skin of the feet 
while the participants’ eyes were closed. The 
monofilament was applied at 10 sites on each foot. 
Any negative response to the monofilament or tun-
ing fork that indicated the possible presence of 
Abbreviations: 
 
ADA American Diabetes Association 
ANOVA analysis of variance 
FPI  foot posture index 
IDF International Diabetes Federation 
kPa kilopascal 
kPa/s/cm2 kilopascal/sec/cm2 
MPJ metatarsophalangeal joint 
NICE National Institute for Health and Care Ex-
cellence 
PTI pressure-time integral 
ROI region of interest 
SIGN Scottish Intercollegiate Guidelines Network 
T2D type 2 diabetes 
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neuropathy resulted in the exclusion of this pa-
tient from the study. 
3.3 Assessment of range of motion 
Participants were then assessed for range of 
motion in the major joints while on a couch in a 
supine position with the use of a goniometer. 
Range of motion testing for the ankle, and the sub-
talar and first metatarsophalangeal joint is shown 
in Table 2. All biomechanical examinations were 
carried out according to accepted clinical practice, 
and detection of biomechanical or structural de-
formity resulted in the exclusion of the participant 
from the study [21]. 
3.4 Foot posture assessment 
Foot posture was assessed using the foot pos-
ture index, which is a validated tool for determin-
ing whether the foot is neutral, supinated, or pro-
nated [22]. Only those participants with a neutral 
foot posture (0 to +5) were included, since both su-
pinated and pronated feet have been shown to al-
ter plantar pressure. 
3.5 Foot plantar pressure assessment 
Each participant was then asked to walk on a 
Tekscan (Boston, USA) HR Mat™ using the two-
step gait protocol, and the participants’ dynamic 
plantar pressures were recorded. This high-
resolution pressure mapping platform (4.1 
sensels/cm2) has been validated previously and 
utilized in a number of similar research projects 
[23]. All data were recorded at 55 Hz. Three trials 
were recorded for each participant while they were 
walking at the participant’s own preferred pace 
and looking straight ahead [24], since this proce-
dure was previously found to be sufficient to en-
sure that plantar pressure and force measure-
ments were reliable [25]. Trials were excluded and 
repeated if the participant made one of the follow-
ing mistakes: 
 
1. Misplacement of the foot on the pressure 
mat 
2. Discontinuation or cancellation of the walk 
on the mat for more than two steps 
 
Standardized instructions were given to par-
ticipants by the same researcher to ensure uni-
formity. 
Table 1. Age and weight parameters of participants in the three 
diabetes duration groups 
 
Parameter Diabetes dura-
tion (yr) 
Sample size 
(n) 
Mean age 
(yr) 
SD 
0-5 12 66.83 6.89 
6-10 12 59.92 4.52 
Duration (yr) 
11-15 12 66.50 4.01 
0-5 12 76.38 9.33 
6-10 12 78.61 8.49 
Weight (kg) 
11-15 12 75.38 7.01 
 
 
Table 2. Biomechanical assessment according to Gastwirth, 1996 
[21] 
 
Assessment Illustration 
Alignment of goniome-
ter for measuring ankle 
joint range of motion 
 
Alignment of goniome-
ter for measuring sub-
talar joint range of mo-
tion  
 
Alignment of goniome-
ter for measuring first 
metatarsophalangeal 
joint dorsiflexion  
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Each trial included eight stance phases: four 
stance phases for the left foot and four for the right 
foot. Before analyzing plantar pressure data, each 
participant’s first and last step was discarded as 
these could have biased the results regarding 
mean values. This procedure was applied as the 
initial step may not be representative of the pa-
tient’s gait style, while the recording of the last 
step could suffer from recording errors. All pres-
sure recordings were performed by using Research 
FootMat™ Software Version 7. We also applied 
masks to mark the areas of interest on the follow-
ing five foot regions: 
 
- Hallux 
- 1st metatarsophalangeal joint (MPJ) 
- 2nd to 4th metatarsophalangeal joints 
- 5th metatarsophalangeal joint and heel 
- Heel 
 
For each compartment, the mean reading of the 
three trials of peak plantar pressure measured in 
kPa, pressure time integral (PTI) measured in 
kPa/cm2, and contact area (cm2) were recorded. 
This process was repeated for the three subject 
groups. 
3.6 Statistical analysis 
We used the Shapiro Wilk test to test normality 
of the distribution of data regarding PTI and peak 
plantar pressure. Given normality, we compared 
mean peak plantar pressure at each foot mask be-
tween the three groups of diabetes duration (0-5, 
6-10, 11-15 years) by using one-way analysis of 
variance (ANOVA). 
A two-way ANOVA regression model was fitted 
to relate peak plantar pressures of the 2nd - 4th MPJ 
to two categorical predictors (diabetes duration, 
foot orientation, and their interaction). The advan-
tage of using statistical modeling is that predictors 
can be analyzed collectively rather than individu-
ally. 
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Figure 1. Mean peak plantar pressure. The figure shows the mean peak plantar pressures for each duration of diabetes (i.e., 0-
5 years, 6-10 years, and 11-15 years) and for each region of interest, as outlined in the column at the right, i.e. hallux, 1st 
metatarsophalangeal joint (MPJ), 2nd - 4th MPJ, and 5th MPJ for both feet. 
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3. Results 
3.1 Comparison analysis 
Figure 1 illustrates the mean peak plantar 
pressure of each foot mask for both the left and 
right foot reported by diabetes duration group. It 
can be seen that there was an increase in both the 
left and right 2nd - 4th MPJ region of interest (ROI) 
mean peak plantar pressure in participants from 
all three groups. The mean peak plantar pressure 
was also observed to increase gradually as the du-
ration of diabetes increases, most significantly in 
the 2nd group (6-10 years) and in the 3rd group (11-
15 years). 
Figure 2 shows the mean PTI of each foot 
mask for both the left and right foot reported by 
diabetes duration group. The figure shows that 
there was an increase in both the left and right 2nd 
- 4th MPJ ROI mean pressure-time integral in par-
ticipants in all three groups. 
Comparison of PTI and peak plantar pressure 
variables between the three groups, i.e. in relation 
to duration of diabetes, showed that mean peak 
plantar pressure values increased gradually as the 
duration of diabetes increased except for hallux, 
left 1st MPJ, and both heels (Table 3). All mean 
peak plantar pressure values increased when com-
paring group 1 to group 3 except for the left hallux. 
3.2 Regression analysis 
Regression analysis was used to relate peak 
plantar pressure of the 2nd - 4th MPJ to two predic-
tors, namely duration of diabetes and foot orienta-
tion (left or right). The test of between-subject ef-
fects (Table 4) was used to identify significant 
predictors of peak plantar pressure of the 2nd - 
4th MPJ. The two-predictor model identified diabe-
tes duration as the sole significant predictor (p < 
0.05). Foot orientation and the interaction effect 
were not found to be significant. This two-predictor 
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Figure 2. Mean pressure-time integral (PTI). The figure shows the PTIs for each duration of diabetes (i.e., 0-5 years, 6-10 
years, and 11-15 years) and for each region of interest, as outlined in the column at the right, i.e. hallux,  1st metatarsopha-
langeal joint (MPJ), 2nd - 4th MPJ, and 5th MPJ for both feet. 
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model explained 21.8% of the total variation in 
peak plantar pressure in the 2nd - 4th MPJ foot re-
gion (r2 = 0.218) (Table 4). 
The graphs in Figure 3 illustrate the results of 
the regression model. They show that mean peak 
plantar pressure varies considerably between the 3 
diabetes duration groups, in particular between 
the first two groups. There is also little variation 
in mean peak plantar pressure between the left 
and right foot, and the lines are fairly parallel, ex-
plaining why the interaction effect was not found 
to be significant. 
Table 5 shows the parameter estimates, indi-
cating how much peak plantar pressure of the 2nd - 
4th MPJ varies between the categories of diabetes 
duration and foot orientation (i.e., left or right). 
The regression coefficient (parameter estimate) for 
duration 0-5 years was -92.347, i.e. the mean peak 
plantar pressure for the first group was 92.347 
KPa less on average than the third group, which 
was statistically significant (p = 0.005). The inter-
cept, as reported in Table 5, is the expected peak 
plantar pressure of the 2nd - 4th MPJ; this is the ex-
pected peak plantar pressure of the 2nd - 
4th MPJ for patients whose diabetes duration is 10-
15 years. 
The coefficient for duration 6-10 years did not 
show statistical significance. All other estimates 
were also insignificant. 
4. Discussion 
This study reports the quantification of peak 
plantar pressure and PTI in participants with dif-
ferent duration of diabetes and no signs of foot de-
formities. Surprisingly, even though there were no 
obvious reasons for increased pressure in patients 
from the >10-year duration group, such as foot or 
toe deformity, they exhibited a mean peak plantar 
pressure of 348 kPa, which exceeds the lowest 
pressure threshold quoted that may cause tissue 
breakdown [26]. Should any of these participants 
develop peripheral arterial disease, neuropathy, or 
any foot deformity, their risk of ulceration would 
increase instantly. 
The mechanism for the formation of this ele-
vated latent peak plantar pressure and PTI in the 
absence of deformity and other obvious confound-
ing factors may be attributable to non-enzymatic 
glycosylation of structural proteins and glycopro-
teins of the plantar soft tissues and overlying skin, 
which alters tissue stiffness and decreases skin 
flexibility. Injury in the diabetic foot is likely to 
initiate ulceration in the deep tissue layers, not on 
the skin surface, with the tissues underlying the 
distal bony prominences of the metatarsals being 
the most susceptible to tissue injury [27]. Skin and 
tissue breakdown may be caused by: 
 
- Reduced flexibility 
- Skin manifestations such as xerosis, cracks, 
or fissures due to altered function of sweat 
glands or damage to autonomic nerve fibers 
[28] 
- Disruption in subcutaneous tissues 
- Micro-hemorrhages 
 
The combination of two or more of these proc-
esses may result in the formation of ulcers [29]. By 
the time ulceration becomes evident, damage to 
Table 3. One-way ANOVA test results for mean peak plantar pres-
sure at all foot regions between the three independent groups clu-
stered by diabetes duration (0-5, 6-10, 11-15 years) 
 
Foot region Diabetes 
duration (yr)
n Mean SD p 
0-5 12 255.11 92.46 
6-10 12 254.05 118.96 
Mean PPP left 
hallux (kPa) 
11-15 12 223.97 90.47 
0.697
 
 
0-5 12 220.46 78.14 
6-10 12 209.67 86.63 
Mean PPP right 
hallux (kPa) 
11-15 12 254.21 77.43 
0.382
 
 
0-5 12 225.93 99.57 
6-10 12 231.74 83.36 
Mean PPP left 1st 
MPJ (kPa) 
11-15 12 281.34 136.18 
0.400
 
 
0-5 12 205.83 70.67 
6-10 12 238.52 117.75 
Mean PPP right 
1st MPJ (kPa) 
11-15 12 247.75 74.72 
0.497
 
 
0-5 12 259.11 42.50 
6-10 12 330.95 84.26 
Mean PPP left 
2nd-4th MPJ 
(kPa) 11-15 12 343.04 76.41 
0.012
 
 
0-5 12 256.58 39.69 
6-10 12 335.77 93.36 
Mean PPP right 
2nd-4th MPJ 
(kPa) 11-15 12 348.92 103.19 
0.022
 
 
0-5 12 182.05 103.28 
6-10 12 182.29 101.99 
Mean PPP left 5th 
MPJ (kPa) 
11-15 12 254.05 145.92 
0.246
 
 
0-5 12 199.46 103.21 
6-10 12 228.79 98.87 
Mean PPP right 
5th MPJ (kPa) 
11-15 12 265.16 109.36 
0.313
 
 
0-5 12 206.81 35.55 
6-10 12 272.92 110.27 
Mean PPP left 
Heel (kPa) 
11-15 12 268.10 37.52 
0.049
 
 
0-5 12 234.43 76.41 
6-10 12 231.41 49.61 
Mean PPP right 
Heel (kPa) 
11-15 12 274.07 42.56 
0.149
 
 
 
Legend: kPa - kilopascal, PPP - peak plantar pressure, SD - standard 
deviation. 
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the underlying structures may already be exten 
the underlying structures may al-
ready be extensive. 
Therefore, clinicians should do 
their utmost actually to prevent 
ulceration through patient educa-
tion, appropriate screening tech-
niques, and, most importantly, 
through the correct clinical bio-
mechanical investigations which 
are known to be valid and reli-
able. Unfortunately, most of the 
time, patients are only assessed 
and treated when some form of 
pathology is already present. 
Although high-peak plantar 
pressure is known to be an impor-
tant risk factor, there is still little 
evidence regarding the causative 
mechanism of ulceration. It is hy-
pothesized that high plantar pres-
sure causes local ischemia in the 
underlying tissues, which conse-
quently results in ulceration. The 
actual threshold of peak plantar 
pressure before ulceration occurs 
has been postulated to be as low 
as 335 kPa [26], which is lower 
than the mean pressure of 348.93 
kPa, as reported in the present 
study. This result suggests the fol-
lowing alternative conclusions: 
 
1. If 335 kPa is indeed the cor-
rect threshold value before 
ulceration, “healthy” diabe-
tes patients may exhibit 
peak plantar pressures that 
are dangerously close to or 
above this point, and the 
only reason why they have 
not ulcerated may be that 
they do not have neuropa-
thy or peripheral arterial 
disease. 
2. 335 kPa is simply too low to 
serve as a cutoff value. 
Higher values may be more 
realistic [17]. 
 
Screening guidelines are 
known to be important for the 
prevention of foot ulceration and 
amputation. However, it is also 
evident that there is a distinct 
lack of scientific evidence regard-
Table 4. Tests of between-subjects effects 
 
Source         Sum of 
       squares
df         Mean
       square
         F         p
Corrected model 109,420.728a 5 21,884.146 3.679 0.005
Intercept 7,026,725.728 1 7,026,725.728 1181.348 0.000
Orientation 133.716 1 133.716 0.022 0.881
Duration 109,034.790 2 5,4517.395 9.166 0.000
Orientation ¯ duration 252.222 2 126.111 0.021 0.979
Error 392,571.942 66 5,948.060   
Total 7,528,718.398 72    
Corrected total 501,992.670 71    
 
Legend: a r2 = 0.218, the measure of the model goodness of fit. F: parameter mean 
square/error mean square. If the F-value increases the p-value decreases. 
 
 
Table 5.  Parameter estimates 
 
Parameter        B        SE        t          p 
Intercept 348.931 22.264 15.673 0.000
Orientation  
   Left -5.887 31.486 -0.187 0.852
   Right 0 . . .
Duration  
   0-5 yr -92.347 31.486 -2.933 0.005
   6-10 yr -13.159 31.486 -0.418 0.677
   11-15 yr 0 . . .
Orientation  
   Left ¯ (duration =  0-5 yr) 8.419 44.527 0.189 0.851
   Left ¯ (duration = 6-10 yr) 1.064 44.527 0.024 0.981
   Left ¯ (duration = 11-15 yr) 0 . . .
   Right ¯ (duration = 0-5 yr) 0 . . .
   Right ¯ (duration = 6-10 yr) 0 . . .
   Right ¯ (duration = 11-15 yr) 0 . . .
 
Legend: Intercept - expected peak plantar pressure of the 2nd - 4th MPJ, B - regression 
coefficient of each parameter, SE - standard error, t - B/SE (if the t-value increases 
the p-value decreases). 
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Figure 3. Two-predictor model relating mean peak plantar pressure to du-
ration of diabetes and foot orientation. The results of the regression model 
showed that duration of diabetes, but not foot orientation (i.e. left or right) is 
a significant predictor of peak plantar pressures. 
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ing the various screening criteria [20]. Foot pres-
sure measuring is a case in point, with the poten-
tial to become a screening guideline since, at the 
moment, there is absolutely no reference to foot 
pressure assessment as a means of preventing foot 
ulceration [30]. The authors thus recommend 
screening for high-peak pressure areas in order to 
assess the risk of ulceration before the actual soft 
tissue damage occurs. 
5. Limitations 
A limitation of the study is the small sample 
size. However, statistical significance was 
achieved with the number of participants included, 
confirming that the findings cannot be attributed 
to chance. Therefore, these results may be consid-
ered as preliminary findings which should encour-
age further research in the field to increase the 
level of evidence for the importance of measuring 
peak plantar pressures in this high-risk popula-
tion. Because of the short duration of the study we 
are also unable to make a statement regarding 
longitudinal development, i.e. we do not know 
whether these individuals actually do ulcerate. 
Therefore, a longitudinal follow-up study would be 
necessary to confirm the results obtained in this 
study. 
Another limitation refers to the population 
studied, which may be representative of a Medi-
terranean, but not a broad European population 
due to the use of open footwear in the former be-
cause of a warmer climate. To address this limita-
tion, it was ensured that data collection took place 
during the winter months when people wear only 
closed footwear, so as to avoid footwear use being a 
confounding variable. Furthermore, the partici-
pants have undergone a diabetes education pro-
gram which specifically advised diabetes patients 
not to wear flip flops or go barefoot as part of their 
daily routine. 
The authors are convinced that the sample 
population was correctly diagnosed as having no 
neuropathy since they were screened using stan-
dard tools, as recommended by common guidelines. 
However, a quantitative measurement of the level 
of neuropathy, e.g. by using the Neuropathy Dis-
ability Score or Michigan Neuropathy Screening 
Instrument, was not performed. 
6. Conclusions 
The results of this study may be important for 
screening purposes. They are also novel since this 
is first report on the occurrence of elevated peak 
plantar pressure in a commonly affected area of 
ulceration at the forefoot in participants living 
with diabetes with no obvious signs of deformity. 
These results confirm that diabetes itself may be a 
cause of increased peak plantar pressure and pres-
sure time integral. Therefore, it is recommended 
that patients who have been living with this condi-
tion for more than 10 years should be regularly 
checked for increased peak plantar pressure even 
in the absence of foot deformity or other foot condi-
tions. Today, advances in foot pressure mapping 
technology, which makes this examination proce-
dure more accessible to practitioners, have made 
this possible. 
 
Disclosures: The authors reported no conflict of inter-
ests. 
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